Skip to content

13F-HR filed by EcoR1 Capital, LLC

EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 32 holding rows worth $253,622,000.

Accession
0001140361-16-076455
Filed
2016-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 32 entries on the cover page, a total value of $253,622,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $253,622,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK2,430,451$31,778,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR439,385$24,373,000thousands by filing date
RETROPHIN INC761299106COM1,225,084$21,819,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW2,139,697$20,306,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM2,943,164$16,335,000thousands by filing date
FIBROGEN INC31572Q808COM788,745$12,943,000thousands by filing date
ACCELERON PHARMA INC00434H108COM371,381$12,620,000thousands by filing date
GILEAD SCIENCES INC375558903COM150,000$12,513,000thousands by filing datecall
ALLERGAN PLCG0177J908COM50,000$11,555,000thousands by filing datecall
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK244,950$9,509,000thousands by filing date
DERMIRA INC24983L104COM272,000$7,956,000thousands by filing date
EPIZYME INC29428V104COM755,046$7,732,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X908COM CL A581,500$7,606,000thousands by filing datecall
KURA ONCOLOGY INC COM50127T109Stock2,465,286$6,681,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM310,695$6,633,000thousands by filing date
ACHAOGEN INC004449104COM1,571,708$5,957,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR175,380$5,226,000thousands by filing date
KINDRED BIOSCIENCES INC COM494577109Stock1,432,765$5,072,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR562,741$4,221,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM357,365$3,520,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM281,776$3,339,000thousands by filing date
XENCOR INC98401F105COMMON STOCK168,000$3,190,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM136,882$3,018,000thousands by filing date
EDITAS MEDICINE INC28106W103COM85,469$2,085,000thousands by filing date
ARRAY BIOPHARMA INC04269X905COM520,000$1,851,000thousands by filing datecall
FORWARD PHARMA A/S34986J105SPONSORED ADR84,332$1,532,000thousands by filing date
IMMUNOGEN INC CMN STK45253H901Cmn299,500$922,000thousands by filing datecall
AKARI THERAPEUTICS PLC00972G108ADR63,468$856,000thousands by filing date
TESARO INC881569107COM9,200$773,000thousands by filing date
ADVAXIS INC007624208COM NEW92,800$751,000thousands by filing date
TARGACEPT INC87611RAA6NOTE 2/1669,166$669,000thousands by filing dateprincipal
EIGER BIOPHARMACEUTICALS INC28249U105COM14,190$281,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-16-076455this filing2016-08-15acceptance time not in the bulk data set